Menu
Not yet recruiting NCT07615920

HILT vs ESWT in Supraspinatus Tendinitis

No phase Interventional Supraspinatus Tendinitis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: High-Intensity Laser Therapy, Extracorporeal Shock Wave Therapy, Conventional Physical Therapy.
Who it may be relevant to
Registry conditions: Supraspinatus Tendinitis. Basic parameters: 18 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Comparative Effectiveness of High-Intensity Laser Therapy Versus Extracorporeal Shock Wave Therapy in Patients With Supraspinatus Tendinitis

Overview

This randomized controlled trial aims to compare the effectiveness of High-Intensity Laser Therapy (HILT) and Extracorporeal Shock Wave Therapy (ESWT) in patients with supraspinatus tendinitis.

Interventions

  • Device High-Intensity Laser Therapy
    High-Intensity Laser Therapy (HILT) is an advanced electrotherapy modality that uses high-power laser energy to penetrate deep musculoskeletal tissues and stimulate biological healing processes. The device emits laser wavelengths ranging between 808-1064 nm with high peak power output, allowing deeper tissue penetration compared to conventional low-level laser therapy. HILT provides analgesic, anti-inflammatory, and biostimulatory effects through increasing local blood circulation, enhancing cel
  • Device Extracorporeal Shock Wave Therapy
    Extracorporeal Shock Wave Therapy (ESWT) is a non-invasive therapeutic modality that delivers high-energy acoustic waves to injured musculoskeletal tissues. The device generates focused or radial shock waves that stimulate tissue healing, neovascularization, pain reduction, and cellular repair mechanisms. ESWT is widely used in the management of tendinopathies, calcific disorders, and chronic musculoskeletal pain. Treatment parameters typically include energy flux density, frequency, number of i
  • Other Conventional Physical Therapy
    The conventional physical therapy program consisted of a combination of therapeutic exercises and physical therapy modalities aimed at reducing pain, improving shoulder range of motion, enhancing muscle strength, and restoring functional performance. The program included hot pack application, Transcutaneous Electrical Nerve Stimulation (TENS), stretching exercises, range of motion exercises, strengthening exercises for the rotator cuff and scapular stabilizers, as well as a home exercise program

Primary outcome measures

  • Pain intensity measured using Visual Analogue Scale (VAS). [Time frame: At baseline and immediately after 4 weeks of intervention]
Secondary outcome measures (4)
  • Shoulder Pain and Disability Measured by the Shoulder Pain and Disability Index (SPADI) [Time frame: At baseline and immediately after 4 weeks of intervention]
  • Upper Extremity Function Measured by the Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH) [Time frame: Time Frame: Baseline and immediately after 4 weeks of intervention.]
  • Shoulder Range of Motion Measured Using a Digital Goniometer [Time frame: Baseline and immediately after 4 weeks of intervention.]
  • Quality of Life Measured by the Short Form-36 Health Survey (SF-36) [Time frame: Baseline and immediately after 4 weeks of intervention.]

Eligibility criteria

Inclusion criteria

  • Male and female participants aged between 18 and 60 years.
  • Clinically diagnosed supraspinatus tendinitis confirmed by ultrasound imaging.
  • Shoulder pain duration greater than 3 months.
  • Ability to understand and follow study instructions.
  • Willingness to participate and provide informed consent.

Exclusion criteria

  • Full-thickness rotator cuff tear.
  • Previous shoulder surgery.
  • Pregnancy.
  • Neurological disorders affecting the upper limb.
  • Corticosteroid injection within the previous 3 months.
  • Shoulder fracture or dislocation.
  • Systemic inflammatory diseases.
  • Participation in other physical therapy programs during the study period

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07615920 · KFSIRB200-1036

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗